Icoreconnect Common Stock Stock Alpha and Beta Analysis
| ICCT Stock | USD 0.17 0.01 5.56% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as iCoreConnect Common stock. It also helps investors analyze the systematic and unsystematic risks associated with investing in ICoreConnect Common over a specified time horizon. Remember, high ICoreConnect Common's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to ICoreConnect Common's market risk premium analysis include:
Beta 2 | Alpha (1.53) | Risk 11.54 | Sharpe Ratio (0.09) | Expected Return (1.04) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
ICoreConnect |
ICoreConnect Common Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. ICoreConnect Common market risk premium is the additional return an investor will receive from holding ICoreConnect Common long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in ICoreConnect Common. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate ICoreConnect Common's performance over market.| α | -1.53 | β | 2.00 |
ICoreConnect Common expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of ICoreConnect Common's Buy-and-hold return. Our buy-and-hold chart shows how ICoreConnect Common performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.ICoreConnect Common Market Price Analysis
Market price analysis indicators help investors to evaluate how ICoreConnect Common stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ICoreConnect Common shares will generate the highest return on investment. By understating and applying ICoreConnect Common stock market price indicators, traders can identify ICoreConnect Common position entry and exit signals to maximize returns.
ICoreConnect Common Return and Market Media
The median price of ICoreConnect Common for the period between Sun, Sep 1, 2024 and Sat, Nov 30, 2024 is 0.35 with a coefficient of variation of 41.04. The daily time series for the period is distributed with a sample standard deviation of 0.14, arithmetic mean of 0.33, and mean deviation of 0.12. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Disposition of tradable shares by Kalish Wayne Edward of ICoreConnect Common subject to Rule 16b-3 | 09/16/2024 |
2 | Insider Trading | 09/27/2024 |
3 | iCoreConnect Inc. Announces Strategic Acquisition of Healthcare Circle of Excellence Assets | 10/03/2024 |
4 | Acquisition by Archit Shah of 2000 shares of ICoreConnect Common at 0.0797 subject to Rule 16b-3 | 10/10/2024 |
5 | Disposition of 126100 shares by Periscope Capital Inc. of ICoreConnect Common subject to Rule 16b-3 | 10/21/2024 |
6 | Disposition of 50000 shares by Fundamental Global Inc. of ICoreConnect Common at 0.2625 subject to Rule 16b-3 | 10/25/2024 |
7 | Disposition of 50000 shares by Fundamental Global Inc. of ICoreConnect Common at 0.2453 subject to Rule 16b-3 | 10/28/2024 |
8 | Disposition of 100000 shares by Fundamental Global Inc. of ICoreConnect Common at 0.2327 subject to Rule 16b-3 | 10/29/2024 |
9 | Disposition of 100000 shares by Fundamental Global Inc. of ICoreConnect Common at 0.2275 subject to Rule 16b-3 | 10/30/2024 |
10 | Disposition of 100000 shares by Fundamental Global Inc. of ICoreConnect Common at 0.1959 subject to Rule 16b-3 | 10/31/2024 |
11 | Discretionary transaction by Pasqual John of tradable shares of ICoreConnect Common subject to Rule 16b-3 | 11/01/2024 |
12 | iCoreConnect Announces Expansion of Endorsement With The Arizona Dental Association | 11/07/2024 |
13 | North Dakota Dental Association Endorses iCoreConnects Comprehensive Product Platform | 11/14/2024 |
14 | Disposition of 47600 shares by Periscope Capital Inc. of ICoreConnect Common subject to Rule 16b-3 | 11/25/2024 |
About ICoreConnect Common Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including ICoreConnect or other stocks. Alpha measures the amount that position in iCoreConnect Common stock has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2021 | 2022 | 2023 | 2024 (projected) | Graham Number | 2.33 | 3.53 | 5.37 | 5.1 | Receivables Turnover | 7.88 | 19.26 | 14.46 | 11.02 |
ICoreConnect Common Upcoming Company Events
As portrayed in its financial statements, the presentation of ICoreConnect Common's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ICoreConnect Common's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of ICoreConnect Common's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of ICoreConnect Common. Please utilize our Beneish M Score to check the likelihood of ICoreConnect Common's management manipulating its earnings.
| 19th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with ICoreConnect Common
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for ICoreConnect Stock Analysis
When running ICoreConnect Common's price analysis, check to measure ICoreConnect Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICoreConnect Common is operating at the current time. Most of ICoreConnect Common's value examination focuses on studying past and present price action to predict the probability of ICoreConnect Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICoreConnect Common's price. Additionally, you may evaluate how the addition of ICoreConnect Common to your portfolios can decrease your overall portfolio volatility.